General Medicine raises $120M in Series B

What did General Medicine announce?

General Medicine said on Oct. 6 that it raised a $120 million Series B led by Andreessen Horowitz. The company is based in San Francisco and was founded in 2023, according to reporting from Startbase and Investing.com.

Andreessen Horowitz said it was backing General Medicine because the company is building a "general store for healthcare." In its announcement, a16z described the product as bringing patient history, clinical guidance, transparent pricing and care access into one experience.

Who joined the round?

Alongside a16z, the round included Matrix, VXI Capital, Eli Lilly, Mercy Health via Granger Management, and BoxGroup, according to Startbase. The firm’s announcement did not appear to break out individual check sizes.

Startbase later reported that the financing brings General Medicine’s total funding to $152 million. A separate report from Investing.com said the company plans to use the money to expand its store into additional categories of care.

What is General Medicine building?

General Medicine appears to be trying to make healthcare feel more like shopping. Independent coverage described the product as an online healthcare marketplace that connects consumers with telemedicine, prescriptions, laboratory services and specialist appointments.

Andreessen Horowitz said the company combines its own medical group with an external clinician marketplace. The firm also said General Medicine has a catalog of more than 2,900 products and services, a figure Startbase independently repeated.

According to a16z, the catalog helps organize patient history, clinical guidance, transparent pricing and access in one flow. In a separate report, General Medicine CEO TJ Parker said the product aims to let users get clinical guidance, shop for care and see costs before deciding.

How is the company positioning its marketplace?

General Medicine’s pitch centers on standardization. LavX reported that the company’s core approach is a catalog that translates how different healthcare actors describe the same service, while a licensed clinician decides clinical appropriateness when needed.

Parker said the catalog is a key differentiator for shopping and navigation. LavX also reported that the system aligns backend standards such as CPT codes with how customers think about offerings and that General Medicine wants to show insurance-based and cash-pay prices side by side.

The company says customers can use direct shopping, clinician consultations or an AI chat interface. LavX reported that General Medicine gathers an average of 11 years of health history per customer and says it has customers across every state and nearly every county, including commercial insurance, Medicare and Medicaid users.

The company also reported self-described outcome metrics: 83% of users said the platform helped address a deferred health need, and one-third had delayed care for more than six months. Those figures were not independently verified in the cited coverage.

What comes next for General Medicine?

The new capital is meant to help General Medicine integrate additional parts of the healthcare market into its platform, according to Startbase. Investing.com said the company wants to expand into additional categories of care.

LavX reported that General Medicine launched nationwide in May 2025 and says hundreds of thousands of customers have already registered. The report also said the company was founded by veterans of PillPack and Amazon Pharmacy, and that the three co-founders previously built PillPack together before Amazon acquired it in 2018 for $750 million.

LavX identified TJ Parker as CEO, Elliot Cohen as president and Ashwin Muralidharan as chief product officer. It also reported that Parker recently moved into the CEO role full-time after serving on the board since the company’s fall 2023 founding and stepping down from Matrix.

Vineeta Agarwala of a16z said General Medicine has built features including one-click record collection, same-day specialist visits and prescription delivery. That gives the company a fairly broad starting point as it tries to become a default entry point for patients who want to compare care options before they commit.